Form4insider filings, from the source

SEC Form 4 · accession 0001645627-18-000049

ENDONOVO THERAPEUTICS, INC. · ENDV

Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗

Reporting owner
Michael Scott Mann
Officer — President · 10% Owner
Period of report
Aug 22, 2018
Accepted (ET)
Aug 28, 2018 · 2:07 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001528172

Table I — non-derivative securities

SecurityDateCodeSharesPriceA/DOwned afterD/INature of ownership
Common StockAug 22, 2018P2,000$0.0244A25,661,198D
Common StockAug 22, 2018P2,000$0.024A25,663,198D
Common StockAug 22, 2018P2,000$0.024A25,665,198D
Common StockAug 22, 2018P2,000$0.0253A25,667,198D
Common StockAug 22, 2018P2,000$0.0263A25,669,198D
Common StockAug 23, 2018P2,000$0.0238A25,671,198D
Common StockAug 23, 2018P5,000$0.0238A25,676,198D
Common StockAug 23, 2018P2,000$0.024A25,678,198D
Common StockAug 23, 2018P3,000$0.0238A25,681,198D
Common StockAug 23, 2018P3,000$0.0247A25,684,198D
Common StockAug 23, 2018P2,000$0.0247A25,686,198D
Common StockAug 23, 2018P3,000$0.0247A25,689,198D
Common StockAug 23, 2018P3,000$0.0247A25,692,198D
Common StockAug 23, 2018P2,000$0.0247A25,694,198D
Common StockAug 23, 2018P3,000$0.0247A25,697,198D
Common StockAug 23, 2018P1,000$0.0247A25,698,198D
Common StockAug 24, 2018P5,000$0.0229A25,703,198D
Common StockAug 24, 2018P2,000$0.0246A25,705,198D
Common StockAug 24, 2018P2,000$0.0249A25,707,198D
Common StockAug 24, 2018P1,000$0.0249A25,708,198D
Common StockAug 24, 2018P2,000$0.0249A25,710,198D
Common StockAug 24, 2018P2,000$0.0249A25,712,198D
Common StockAug 24, 2018P5,000$0.0249A25,717,198D
Common StockAug 24, 2018P500$0.025A25,717,698D
Common StockAug 24, 2018P2,000$0.0248A25,719,698D
Common StockAug 24, 2018P3,000$0.0246A25,722,698D

Table II — derivative securities

No Table II lines on this filing.